6051. Treatment-Free Remission After Second-Line Nilotinib Treatment in Patients With Chronic Myeloid Leukemia in Chronic Phase: Results From a Single-Group, Phase 2, Open-Label Study.
作者: François-Xavier Mahon.;Carla Boquimpani.;Dong-Wook Kim.;Noam Benyamini.;Nelma Cristina D Clementino.;Vasily Shuvaev.;Sikander Ailawadhi.;Jeffrey Howard Lipton.;Anna G Turkina.;Raquel De Paz.;Beatriz Moiraghi.;Franck E Nicolini.;Jolanta Dengler.;Tomasz Sacha.;Naoto Takahashi.;Rafik Fellague-Chebra.;Sandip Acharya.;Stephane Wong.;Yu Jin.;Timothy P Hughes.
来源: Ann Intern Med. 2018年168卷7期461-470页
Treatment-free remission (TFR)-that is, stopping tyrosine kinase inhibitor (TKI) therapy without loss of response-is an emerging treatment goal in chronic myeloid leukemia (CML).
6060. Benefits and Harms of Cranial Electrical Stimulation for Chronic Painful Conditions, Depression, Anxiety, and Insomnia: A Systematic Review.
作者: Paul G Shekelle.;Ian A Cook.;Isomi M Miake-Lye.;Marika Suttorp Booth.;Jessica M Beroes.;Selene Mak.
来源: Ann Intern Med. 2018年168卷6期414-421页
Cranial electrical stimulation (CES) is increasingly popular as a treatment, yet its clinical benefit is unclear.
|